Roger Strode Discusses Impact of Proposed Noncompete Clause Ban on Health Care Sector
January 11, 2023
Healthcare Dive
Foley & Lardner LLP Partner Roger Strode is quoted in the Healthcare Dive article, “Doctors no longer bound by noncompetes under FTC’s proposed ban,” discussing the potential impact on the health care sector of a rule put forward by the Federal Trade Commission (FTC) that would prohibit companies from requiring workers to sign noncompete clauses.
Strode explained that abolishing noncompetes may not be enforceable in nonprofit organizations, which are widespread in the health care sector. “The FTC may not have the authority under the FTC Act to impose this rule on nonprofit organizations,” he said.
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.